Literature DB >> 22192877

Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population.

Heather E Moss1, Leo McCluskey, Lauren Elman, Katelin Hoskins, Lauren Talman, Murray Grossman, Laura J Balcer, Steven L Galetta, Grant T Liu.   

Abstract

OBJECTIVE: Ocular motility abnormalities may be a marker of neuro-degeneration beyond motor neurons in amyotrophic lateral sclerosis (ALS). We formally compared clinical neuro-ophthalmic abnormalities in ALS patients and a control population.
METHODS: Patients attending a multidisciplinary ALS clinic (n=63, age 60.8+/-16.4 years) and their caregivers serving as controls (n=37, ages 55.0+/-12.7 years) participated in this cross-sectional study. Visual acuity was assessed. Video recordings of a standardized ocular motility exam including gaze fixation, voluntary saccades, reflex saccades, smooth pursuit, eyelid opening and Bell's phenomenon were rated by two senior neuro-ophthalmologists who were masked to subject group.
RESULTS: Visual acuity was lower in ALS patients versus control subjects (OR 0.81 (0.71-0.93), p=0.003, logistic regression). Inter- and intra-rater reliability for ocular motility examination ratings were good (Cohen's Kappa>0.6). Findings observed only in ALS subjects included gaze impersistence (14%, p=0.01), moderately or severely restricted voluntary upgaze (13%, p=0.01), and moderate or severe eyelid opening apraxia (27%, p=0.0002). Accounting for age, moderately or severely saccadic horizontal smooth pursuits distinguished ALS from control subjects (OR 3.6 (1.2-10.9), p=0.02, logistic regression).
CONCLUSIONS: Clinical findings of decreased visual acuity, gaze impersistence, voluntary upgaze restriction, eyelid opening apraxia, and saccadic horizontal smooth pursuits are more frequent in patients with ALS than in similar-aged controls. These findings are potential clinical markers of neurodegeneration beyond upper and lower motor neuron disease in ALS. Further study is warranted regarding their application to disease categorization and outcomes assessment.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22192877      PMCID: PMC3441141          DOI: 10.1016/j.jns.2011.10.016

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  35 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study.

Authors:  K R Chaudhuri; S Crump; S al-Sarraj; V Anderson; J Cavanagh; P N Leigh
Journal:  J Neurol Sci       Date:  1995-05       Impact factor: 3.181

3.  Effects of stimulus velocity and acceleration on smooth pursuit in motor neuron disease.

Authors:  L A Abel; I M Williams; K L Gibson; L Levi
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

4.  Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements.

Authors:  P J Whitehouse; J K Wamsley; M A Zarbin; D L Price; M J Kuhar
Journal:  Ann Neurol       Date:  1985-05       Impact factor: 10.422

5.  Human extraocular muscles in ALS.

Authors:  Mahboobah Ahmadi; Jing-Xia Liu; Thomas Brännström; Peter M Andersen; Per Stål; Fatima Pedrosa-Domellöf
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-24       Impact factor: 4.799

6.  Eye movement in amyotrophic lateral sclerosis: a longitudinal study.

Authors:  A Palmowski; W H Jost; J Prudlo; J Osterhage; B Käsmann; K Schimrigk; K W Ruprecht
Journal:  Ger J Ophthalmol       Date:  1995-11

7.  Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.

Authors:  Claudia Ramaker; Johan Marinus; Anne Margarethe Stiggelbout; Bob Johannes Van Hilten
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

8.  Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.

Authors:  Felix Geser; Nicholas J Brandmeir; Linda K Kwong; Maria Martinez-Lage; Lauren Elman; Leo McCluskey; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski
Journal:  Arch Neurol       Date:  2008-05

9.  Oculomotor abnormalities in motor neuron disease.

Authors:  J Marti-Fàbregas; C Roig
Journal:  J Neurol       Date:  1993-09       Impact factor: 4.849

10.  Slow vertical saccades in motor neuron disease: correlation of structure and function.

Authors:  L Averbuch-Heller; C Helmchen; A K Horn; R J Leigh; J A Büttner-Ennerver
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

View more
  21 in total

Review 1.  Human visual skills for brain-computer interface use: a tutorial.

Authors:  Melanie Fried-Oken; Michelle Kinsella; Betts Peters; Brandon Eddy; Bruce Wojciechowski
Journal:  Disabil Rehabil Assist Technol       Date:  2020-06-01

2.  Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation.

Authors:  Amani A Fawzi; Joseph M Simonett; Patryk Purta; Heather E Moss; Jessica L Lowry; Han-Xiang Deng; Nailah Siddique; Robert Sufit; Eileen H Bigio; Nicholas J Volpe; Teepu Siddique
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-16       Impact factor: 4.092

3.  Workshops of the Seventh International Brain-Computer Interface Meeting: Not Getting Lost in Translation.

Authors:  Jane E Huggins; Christoph Guger; Erik Aarnoutse; Brendan Allison; Charles W Anderson; Steven Bedrick; Walter Besio; Ricardo Chavarriaga; Jennifer L Collinger; An H Do; Christian Herff; Matthias Hohmann; Michelle Kinsella; Kyuhwa Lee; Fabien Lotte; Gernot Müller-Putz; Anton Nijholt; Elmar Pels; Betts Peters; Felix Putze; Rüdiger Rupp; Gerwin Schalk; Stephanie Scott; Michael Tangermann; Paul Tubig; Thorsten Zander
Journal:  Brain Comput Interfaces (Abingdon)       Date:  2019-12-10

4.  In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis.

Authors:  A Abdelhak; A Hübers; K Böhm; A C Ludolph; J Kassubek; E H Pinkhardt
Journal:  J Neurol       Date:  2018-02-20       Impact factor: 4.849

5.  Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).

Authors:  Nicholas J Volpe; Joseph Simonett; Amani A Fawzi; Teepu Siddique
Journal:  Trans Am Ophthalmol Soc       Date:  2015

6.  Validation of Simplified Visual Acuity Testing Protocols in Amyotrophic Lateral Sclerosis.

Authors:  Lindsay C Boven; Qin Li Jiang; Heather E Moss
Journal:  Neuroophthalmology       Date:  2017-04-27

7.  Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Lindsay Boven; Qin Li Jiang; Heather E Moss
Journal:  Neuroophthalmology       Date:  2017-06-01

8.  Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging.

Authors:  Annemarie Hübers; Hans Peter Müller; Jens Dreyhaupt; Kathrin Böhm; Florian Lauda; Hayrettin Tumani; Jan Kassubek; Albert C Ludolph; Elmar H Pinkhardt
Journal:  J Neural Transm (Vienna)       Date:  2015-11-18       Impact factor: 3.575

9.  Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.

Authors:  Sushant Puri; Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2017-11-28

10.  Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Authors:  Malcolm Proudfoot; Ricarda A L Menke; Rakesh Sharma; Claire M Berna; Stephen L Hicks; Christopher Kennard; Kevin Talbot; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.